By stabilizing GLP-1R in its active conformation, exenatide enhances glucose-stimulated insulin secretion, suppresses glucagon release, and slows gastric emptying—actions critical for managing type 2 diabetes mellitus [48,49]. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.